Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3SAS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,405
Award facts
- Contract value 100% obligated
- $12,404.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Dupixent 300 mg/2 mL pens valued at $12,404.58 with completion scheduled for December 22, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other government entities. Dupixent, a biologic immunosuppressant medication used primarily for moderate-to-severe atopic dermatitis and other allergic conditions, addresses therapeutic needs within the Defense Health Agency's broader pharmaceutical supply chain. This delivery order exemplifies the company's ongoing role in fulfilling DLA's medical supply requirements through flexible contract vehicles that enable responsive procurement across multiple therapeutic domains to support military readiness and servicemember healthcare.
Quick answers
Who was awarded contract SPE2DR26F3SAS?
SPE2DR26F3SAS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F3SAS worth?
The government has obligated $12,405 on SPE2DR26F3SAS.
Is contract SPE2DR26F3SAS an order under another contract?
Yes. SPE2DR26F3SAS is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3SAS competed?
The extent of competition for SPE2DR26F3SAS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award